Shaheen Uzma, Akka Jyothy, Hinore Jitendra Singh, Girdhar Amandeep, Bandaru Srinivas, Sumithnath Tharaparambil Gangadharan, Nayarisseri Anuraj, Munshi Anjana
Institute of Genetics and Hospital for Genetic Diseases, Osmania University, Hyderabad - 500 016, Telangana, India.
In silico Research Laboratory, Eminent Biosciences, Indore - 452 010, Madhya Pradesh, India.
Bioinformation. 2015 Mar 31;11(3):131-7. doi: 10.6026/97320630011131. eCollection 2015.
Phenytoin (PHT) and Carbamazepine (CBZ) are excellent sodium channel blockers administered in clinical treatment of epileptic seizures. However, the narrow therapeutic range and limited pharmacokinetics of these drugs have raised serious concerns in the proper management of epilepsy. To overcome this, the present study attempts to identify a candidate molecule with superior pharmacological profile than PHT and CBZ through In silico approaches. PHT and CBZ served as query small molecules for Tanimoto based similarity search with a threshold of 95% against PubChem database. Aided by MolDock algorithm, high affinity similar compound against each query was retrieved. PHT and CBZ and their respective similar were further tested for toxicity profiles, LC 50 values and biological activity. Compounds, NSC403438 and AGN-PC-0BPCBP respectively similar to PHT and CBZ demonstrated higher affinity to sodium channel protein than their respective leads. Of particular relevance, NSC403438 demonstrated highest binding affinity bestowed with least toxicity, better LC 50 values and optimal bioactivity. NSC403438 was further mapped for its structure based pharmacophoric features. In the study, we report NSC403438 as potential sodium channel blocker as a better candidate than PHT and CBZ which can be put forth for pharmacodynamic and pharmacokinetic studies.
AEDs - Antiepileptic drugs, BLAST - Basic Local Alignment Search Tool, CBZ - Carbamazepine, GEFS+ - Generalized Epilepsy with Febrile Seizures Plus, GPCR - G Protein Coupled Receptor, Nav - Sodium channel with specific voltage conduction, PDB - Protein Data Bank, PHT - Phenytoin, PIR - Protein Information resources, SAVES - Structural Analysis and Verification Server, VGSC - Voltage-gated Sodium channels.
苯妥英(PHT)和卡马西平(CBZ)是用于癫痫发作临床治疗的优秀钠通道阻滞剂。然而,这些药物狭窄的治疗范围和有限的药代动力学在癫痫的合理管理方面引发了严重担忧。为克服这一问题,本研究试图通过计算机模拟方法鉴定一种药理学特性优于PHT和CBZ的候选分子。PHT和CBZ用作基于Tanimoto相似性搜索的查询小分子,以95%的阈值在PubChem数据库中进行搜索。在MolDock算法的辅助下,检索到针对每个查询的高亲和力相似化合物。对PHT和CBZ及其各自的相似物进一步测试毒性特征、半数致死浓度(LC50)值和生物活性。分别与PHT和CBZ相似的化合物NSC403438和AGN-PC-0BPCBP对钠通道蛋白的亲和力高于其各自的先导化合物。特别相关的是,NSC403438表现出最高的结合亲和力,毒性最小,LC50值更好且生物活性最佳。进一步绘制了NSC403438基于结构的药效团特征。在本研究中,我们报告NSC403438作为潜在的钠通道阻滞剂,是比PHT和CBZ更好的候选物,可用于药效学和药代动力学研究。
AEDs - 抗癫痫药物,BLAST - 基本局部比对搜索工具,CBZ - 卡马西平,GEFS+ - 伴有热性惊厥附加症的全身性癫痫,GPCR - G蛋白偶联受体,Nav - 具有特定电压传导的钠通道,PDB - 蛋白质数据库,PHT - 苯妥英,PIR - 蛋白质信息资源,SAVES - 结构分析与验证服务器,VGSC - 电压门控钠通道